A letter from NORD thanking the House Committee on Energy and Commerce for its leadership on the 21st Century Cures Act (H.R.6) has been signed by 200 rare disease patient organizations. The letter affirms NORD’s support for the legislation and notes specifically that the increased funding for the National Institutes of Health (NIH) and Food and Drug Administration (FDA) mandated in the legislation could “greatly improve the discovery, development, and delivery of treatments and cures” for underserved patient communities.